ロード中...
Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
Diabetes mellitus currently affects over 350 million patients worldwide and is associated with many deaths from cardiovascular complications. Sodium–glucose co-transporter 2 (SGLT-2) inhibitors are a novel class of antidiabetic drugs with cardiovascular benefits beyond other antidiabetic drugs. In t...
保存先:
| 出版年: | Cardiovasc Diabetol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6038192/ https://ncbi.nlm.nih.gov/pubmed/29991346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-018-0745-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|